Lucy Roxana Haggstrom

6PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 22, 2024
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes.

Lucy Haggstrom, Yeh Chen Lee, Clare Scott

|Aug 26, 2023
Antibody-Drug Conjugates: Ushering in a New Era of Cancer Therapy.

Joshua Hurwitz, Lucy Roxana Haggstrom, Elgene Lim

|Feb 25, 2022
Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review.

Lucy R Haggstrom, Janette L Vardy, Emma-Kate Carson

|Jul 31, 2020
Factors influencing recurrence of stage I-III rectal cancer in regional Australia.

Lucy Haggstrom, Sharlyn Kang, Robert Winn

Pageof 1